Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-08

Clinical Trial Update: Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating add-on allopurinol versus placebo in patients with schizophrenia (including schizoaffective disorder); the study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: Sheba Medical Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED